Recent changes

From OpenWetWare
Jump to navigationJump to search

Track the most recent changes to the wiki on this page.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 16:40, 21 May 2024
   
 
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

21 May 2024

     10:58  YAEL‎‎ 2 changes history −77 [Michael S Beauchamp‎ (2×)]
     
10:58 (cur | prev) +1 Michael S Beauchamp talk contribs
     
10:58 (cur | prev) −78 Michael S Beauchamp talk contribs
     08:18  Mechanobiology and Microscale Devices - Neeraj, Robert Sterian, Eugene Cheong, Luke Boudreau, Bridgit Foss‎‎ 8 changes history −444 [Sarah L. Perry‎ (8×)]
     
08:18 (cur | prev) −444 Sarah L. Perry talk contribs (→‎Pressure effects on cells)
     
08:14 (cur | prev) −74 Sarah L. Perry talk contribs (→‎Micropatterning and Cell Studies)
     
08:11 (cur | prev) +17 Sarah L. Perry talk contribs (→‎Micropatterning)
     
08:09 (cur | prev) +29 Sarah L. Perry talk contribs (→‎Relevance of CTFs)
 m   
08:05 (cur | prev) −2 Sarah L. Perry talk contribs (→‎Strain, stretching, and stiffness in blood vessels)
 m   
08:04 (cur | prev) −1 Sarah L. Perry talk contribs (→‎Transendothelial and interstitial flow in blood vessels)
     
08:02 (cur | prev) +1 Sarah L. Perry talk contribs (→‎Types of mechanical stimulus)
 m   
07:57 (cur | prev) +30 Sarah L. Perry talk contribs
     07:52  CHEM-ENG590E:Wiki Textbook diffhist +14 Sarah L. Perry talk contribs (→‎Chapter 9 - Microfluidics and Cell Culture)
     07:46  Flow and Pattern Asymmetries‎‎ 9 changes history +76 [Sarah L. Perry‎ (9×)]
     
07:46 (cur | prev) +123 Sarah L. Perry talk contribs (→‎Microfluidics in Lipidic Mesophases for Membrane Protein Crystallization)
     
07:40 (cur | prev) −409 Sarah L. Perry talk contribs
     
07:40 (cur | prev) +146 Sarah L. Perry talk contribs (→‎Pneumatic Valves and Mixers)
     
07:35 (cur | prev) +68 Sarah L. Perry talk contribs (→‎Asymmetries in Microfluidics)
 m   
07:34 (cur | prev) 0 Sarah L. Perry talk contribs (→‎Recirculating Plugs)
     
07:31 (cur | prev) −17 Sarah L. Perry talk contribs (→‎Chaotic Advection)
 m   
07:29 (cur | prev) +3 Sarah L. Perry talk contribs (→‎Stokes Flow)
 m   
07:27 (cur | prev) +2 Sarah L. Perry talk contribs (→‎Stokes Flow)
     
07:22 (cur | prev) +160 Sarah L. Perry talk contribs (→‎Asymmetries in Microfluidics)

20 May 2024

     19:36  CHEM-ENG590E:Wiki Textbook diffhist −125 Sarah L. Perry talk contribs (→‎Chapter 9 - Microfluidics and Cell Culture)
     19:33  Organ/Tumor/Body-on-a-Chip - Organ on a Chip - Michele Caggioni‎‎ 29 changes history −2,893 [Sarah L. Perry‎ (29×)]
     
19:33 (cur | prev) −2,021 Sarah L. Perry talk contribs
     
19:32 (cur | prev) +69 Sarah L. Perry talk contribs (→‎Future Work and Ultimate Goals)
     
19:31 (cur | prev) −3 Sarah L. Perry talk contribs (→‎Body-on-a-chip Limitations)
     
19:30 (cur | prev) +9 Sarah L. Perry talk contribs (→‎Body-on-a-chip Advantages)
     
19:28 (cur | prev) +2 Sarah L. Perry talk contribs
     
19:25 (cur | prev) +523 Sarah L. Perry talk contribs (→‎Scalability of Tumor-On-A-Chip Based Drug Screening)
     
19:25 (cur | prev) +1,250 Sarah L. Perry talk contribs (→‎Drug Screening)
     
19:20 (cur | prev) −1,679 Sarah L. Perry talk contribs (→‎Body-on-a-chip Limitations)
     
19:19 (cur | prev) −355 Sarah L. Perry talk contribs
     
19:12 (cur | prev) −31 Sarah L. Perry talk contribs (→‎Organ-on-a-Chip Advantages and Disadvantages)
     
19:11 (cur | prev) +8 Sarah L. Perry talk contribs (→‎Body-on-a-chip Advantages)
     
19:10 (cur | prev) −100 Sarah L. Perry talk contribs (→‎Body-on-a-chip (integration of multiple organ-on-a-chips) Advantages & Limitations)
     
19:08 (cur | prev) +4 Sarah L. Perry talk contribs (→‎Scalability of Tumor-On-A-Chip Based Drug Screening)
     
19:07 (cur | prev) −480 Sarah L. Perry talk contribs (→‎Scalability of Tumor-On-A-Chip Based Drug Screening)
     
19:02 (cur | prev) −40 Sarah L. Perry talk contribs (→‎Drug Screening)
     
18:58 (cur | prev) −14 Sarah L. Perry talk contribs (→‎Modeling)
     
18:56 (cur | prev) −134 Sarah L. Perry talk contribs (→‎Tumor Spheroid Production)
     
18:52 (cur | prev) +3 Sarah L. Perry talk contribs (→‎Tumor Spheroid Production)
 m   
18:51 (cur | prev) −1 Sarah L. Perry talk contribs (→‎Role of Microfluidics in Cancer Research)
     
18:51 (cur | prev) +9 Sarah L. Perry talk contribs (→‎Role of Microfluidics in Cancer Research)
 m   
18:50 (cur | prev) +21 Sarah L. Perry talk contribs (→‎Role of Microfluidics in Cancer Research Abroad)
     
18:46 (cur | prev) +9 Sarah L. Perry talk contribs (→‎Modeling Drug Delivery: Overview and Motivation)
     
18:45 (cur | prev) +4 Sarah L. Perry talk contribs (→‎Modeling Non-Cancerous Cell Components of the Tumor Microenvironment)
     
18:45 (cur | prev) +14 Sarah L. Perry talk contribs (→‎Modeling Non-Cancerous Cell Components of the Tumor Microenvironment)
     
18:45 (cur | prev) −4 Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)
     
18:44 (cur | prev) +12 Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)
     
18:44 (cur | prev) +8 Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)
     
18:43 (cur | prev) +14 Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)
     
18:43 (cur | prev) +10 Sarah L. Perry talk contribs (→‎Modeling Non-Cancerous Cell Components of the Tumor Microenvironment)